Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 3:08 PM UTC
| NCT Number | NCT06947993 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE2 |
| Target Enrollment | 224 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of September 1, 2026: Clinical trial NCT06947993 is currently recruiting participants. This phase2 study for atopic dermatitis is actively seeking new participants at 24 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06947993 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06947993 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.